hydroxyurea has been researched along with mycophenolic acid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aburai, N; Fujisawa, N; Kawada, M; Kimura, K; Koshino, H; Ohba, S; Sakamoto, Y; Tsuchiya, E; Uesugi, S; Yamori, T | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Henderson, JF; Lowe, JK | 1 |
| McDonald, CJ | 3 |
| Klem, EB | 1 |
| Abel, EA; Farber, EM; Pearlman, D | 1 |
| Schiff, M | 1 |
| Fischer, M; Ott, P; Schläpfer, E; Speck, RF | 1 |
| Fumero, E; García, F; Gatell, JM | 1 |
| Foli, A; Lisziewicz, J; Lori, F; Maiocchi, MA | 1 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Abraham, A; Cluster, A; Delgado, D; Hulbert, ML; Jacobsohn, D; Kukadiya, D; Murray, L; Shenoy, S | 1 |
| Lim, YL; Toh, JJ; Yew, YW | 1 |
6 review(s) available for hydroxyurea and mycophenolic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An appraisal of current systemic chemotherapy for psoriasis.
Topics: Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azauridine; Cell Division; Female; Humans; Hydroxyurea; Kinetics; Methotrexate; Methoxsalen; Mycophenolic Acid; Psoriasis; Ultraviolet Therapy | 1976 |
Chemotherapy of psoriasis.
Topics: Azauridine; Central Nervous System; Digestive System; Hematopoietic System; Humans; Hydroxyurea; Liver; Methotrexate; Mycophenolic Acid; Psoriasis | 1975 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; Hydroxyurea; Mercaptopurine; Mustard Compounds; Mycophenolic Acid; Psoriasis | 1981 |
Emerging treatments for rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antirheumatic Agents; Arthritis, Rheumatoid; CD4 Antigens; Collagen; Cyclosporine; Humans; Hydroxyurea; Immunosuppressive Agents; Interleukin-1; Minocycline; Mycophenolic Acid; Tumor Necrosis Factor-alpha | 1997 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
1 trial(s) available for hydroxyurea and mycophenolic acid
| Article | Year |
|---|---|
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
Topics: Alemtuzumab; Anemia, Sickle Cell; Calcineurin Inhibitors; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Hydroxyurea; Male; Melphalan; Mycophenolic Acid; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine | 2017 |
11 other study(ies) available for hydroxyurea and mycophenolic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Asteraceae; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Plants, Edible; Sesquiterpenes; Structure-Activity Relationship | 2012 |
Enhancement by caffeine of the growth inhibitory effects of antimetabolites in lymphoma L5178Y cells.
Topics: Antimetabolites; Caffeine; Cell Division; Cells, Cultured; Deoxyadenosines; Drug Synergism; Hydroxyurea; In Vitro Techniques; Lymphoma; Methotrexate; Methylthioinosine; Mycophenolic Acid; Neoplasms, Experimental; Time Factors | 1977 |
When to try antineoplastic agents in psoriasis.
Topics: Antineoplastic Agents; Azauridine; Humans; Hydroxyurea; Kidney Function Tests; Liver Function Tests; Methotrexate; Mycophenolic Acid; Psoriasis | 1977 |
Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture.
Topics: Animals; Anthralin; Antimetabolites; Azauridine; Cell Division; Cells, Cultured; Cycloheximide; Cytarabine; Dactinomycin; Daunorubicin; Guinea Pigs; Hydroxyurea; Methotrexate; Mycophenolic Acid; Psoriasis; Puromycin; Skin | 1978 |
Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; DNA, Viral; Dose-Response Relationship, Drug; Drug Combinations; Flow Cytometry; HIV-1; Humans; Hydroxyurea; Isoxazoles; Leflunomide; Leukocytes, Mononuclear; Mycophenolic Acid | 2003 |
Immunosuppressive drugs as an adjuvant to HIV treatment.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Hydroxyurea; Immunosuppressive Agents; Mycophenolic Acid; Nucleic Acid Synthesis Inhibitors | 2004 |
A checkpoint in the cell cycle progression as a therapeutic target to inhibit HIV replication.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Gene Expression Regulation, Viral; HIV-1; Humans; Hydroxyurea; Mycophenolic Acid; Virus Replication | 2007 |
Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cyclosporine; Disease Management; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pemphigoid, Bullous; Pemphigus; Psoriasis; Retrospective Studies; Ultraviolet Therapy | 2019 |